Timothy R Franson Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

Timothy R Franson is Director of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 72,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Timothy R Franson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 21 2023	SELL Sale (or disposition) back to the issuer	-	72,000 Reduced 100.0%	0 Common Stock
Feb 21 2023	SELL Open market or private sale	$13,160 $1.88 p/Share	7,000 Reduced 8.86%	72,000 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	20,000 Added 20.2%	79,000 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	20,000 Added 25.32%	59,000 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	9,000 Added 18.75%	39,000 Common Stock

Also insider at

CDTX

Cidara Therapeutics, Inc. Healthcare

Director

TRF